Stengone Carmine N.

Stengone Carmine N. is listed in public filings as director, officer: CEO and President. This Stengone Carmine N. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Contineum Therapeutics, Inc. Class A Common Stock (CTNM), and Kiora Pharmaceuticals, Inc. (KPRX). Investors use Stengone Carmine N.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.